CompletedNot Applicable

Effect of Left Posterior Pericardiotomy for the Prevention of POAF

South Korea270 participantsStarted 2023-12-11

Plain-language summary

This study is planned to evaluate the effect of left posterior pericardiotomy for the prevention of postoperative atrial fibrillation after coronary artery bypass grafting. Eligible patients will be randomized to be created or not to be created the left posterior pericardiotomy at the end of the operation, and the incidence of postoperative atrial fibrillation will be compared.

Who can participate

Age range

19 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * patients who are planned to undergo coronary artery bypass grafting * patients aged ≥19 years Exclusion Criteria: * patients who are planned to undergo other concomitant cardiac procedures (e.g. valve procedures, aorta procedures) * patients who undergo coronary artery bypass grafting using cardiopulmonary bypass * patients who are documented with paroxysmal, persistent, or permanent atrial fibrillation before operation * patients who have a history of cardiac surgery * patients who have a history of pericardial disease * patients who have severe adhesion at left pleural cavity which precludes effective left posterior pericardiostomy * patients who refuse to participate in this study

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

occurence rate of postoperative atrial fibrillation

Timeframe: From date of operation until postoperative day 7

Trial details

NCT IDNCT06159985

SponsorSeoul National University Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-12-09

View on ClinicalTrials.gov More Coronary Artery Disease trials